Study points to remotely supervised exercise classes as best option during lockdown

Based on data for 344 volunteers, Brazilian researchers compared the physical and mental health benefits of workouts led in person by a fitness instructor, unsupervised online sessions, and classes supervised remotely via video call

Interaction identified between SARS-CoV-2 and unusual RNA structures in human cells

Replication of SARS-CoV-2, the virus responsible for COVID-19, depends on a series of interactions between viral proteins and different cellular partners such as nucleic acids (DNA or RNA). Characterizing these interactions is crucial to elucidate the process of viral replication…

New method predicts COVID-19 severity, could help with hospital triage

During the height of the pandemic, some hospitals were overwhelmed with patients seeking treatment for COVID-19. This situation could happen again during future outbreaks, especially with SARS-CoV-2 variants of concern on the rise. Now, researchers reporting in ACS’ Analytical Chemistry…

Toward one drug to treat all coronaviruses

Safe and effective vaccines offer hope for an end to the COVID-19 pandemic. However, the possible emergence of vaccine-resistant SARS-CoV-2 variants, as well as novel coronaviruses, make finding treatments that work against all coronaviruses as important as ever. Now, researchers…

Association between COVID-19 exposure, self-reported compliance with public health guidelines among essential employees at an institution of higher education

What The Study Did: This study at an institution of higher education in Colorado evaluated the association between self-reported protective behaviors and how common SARS-CoV-2 infection was among essential in-person employees during the first six months of the COVID-19 pandemic…

CEPI and IVI collaborate on clinical research to expand access to COVID-19 vaccines in Africa

July 20, 2021; Oslo, Norway and Seoul, Republic of Korea: The Coalition for Epidemic Preparedness Innovations (CEPI) and the International Vaccine Institute (IVI) today announced a new programme of clinical research which aims to expand access to COVID-19 vaccines in…

The Lancet: 1.5 million children worldwide have lost parent, grandparent, caregiver due to COVID-19

Study offers first global estimates of the number of children who experienced the death of a parent, grandparent, or primary caregiver from COVID-19. Researchers estimated figures based on COVID-19 mortality data from March 2020 through April 2021, and national fertility…

COVID-19-related immigration concerns among Latinx immigrants in US

What The Study Did: T hese results suggest that substantial proportions of Latinx immigrants have immigration concerns about engaging in COVID-19-related testing, treatment and contact tracing. Authors: Carol L. Galletly, J.D., Ph.D., Medical College of Wisconsin in Milwaukee, i s…

Exploring gap between excess mortality, COVID-19 deaths in 67 countries

What The Study Did: N ational health care systems have different capacities to correctly identify people who died of COVID-19. Researchers in this study analyzed the gap between excess mortality and  COVID-19 confirmed mortality in 67 countries to determine the…

Primary care payment model, telemedicine use for Medicare Advantage during pandemic

What The Study Did: The association between primary care payment models and the use of telemedicine for Medicare Advantage enrollees during the COVID-19 pandemic was examined in this study. Authors: Brian W. Powers, M.D., M.B.A., of Humana Inc. in Louisville,…

New COVID-19 vaccine candidate provides effective option for low- to mid-income countries

A multidisciplinary team of researchers is the first to show combining yeast-expression technology and a novel adjuvant formulation to produce a COVID-19 vaccine candidate is effective against SARS-COV-2 and promises to be easy to produce at large scale and cost-effective, important aspects for vaccinating people worldwide, especially in low- to middle-income countries.